Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Cancer × Vemurafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 8 Neoplasms 7 Thyroid Neoplasms 4 Thyroid Cancer, Papillary 4 Neoplasm Metastasis 4 Leukemia, Hairy Cell 4 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Carcinoma, Anaplastic 2 Skin Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Hematologic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid cancer, follicular 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan syndrome 3 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1

Interventions

Nivolumab 6 Ipilimumab 2 Gemcitabine 2 zaleplon 1 temsirolimus 1 relatlimab 1 regorafenib 1 linrodostat 1 Vorinostat 1 Trastuzumab 1 Standard of Care 1 Sirolimus 1 Rehabilitation 1 Paclitaxel 1 Oxaliplatin 1 Injections 1 IFL protocol 1 Health Services Needs and Demand 1 Everolimus 1 Clinical Trials, Phase IV as Topic 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡